Literature DB >> 29254838

The impact of selection bias on vaccine effectiveness estimates from test-negative studies.

Michael L Jackson1, C Hallie Phillips2, Joyce Benoit2, Erika Kiniry2, Lawrence Madziwa2, Jennifer C Nelson2, Lisa A Jackson2.   

Abstract

INTRODUCTION: Estimates of vaccine effectiveness (VE) from test-negative studies may be subject to selection bias. In the context of influenza VE, we used simulations to identify situations in which meaningful selection bias can occur. We also analyzed observational study data for evidence of selection bias.
METHODS: For the simulation study, we defined a hypothetical population whose members are at risk for acute respiratory illness (ARI) due to influenza and other pathogens. An unmeasured "healthcare seeking proclivity" affects both probability of vaccination and probability of seeking care for an ARI. We varied the direction and magnitude of these effects and identified situations where meaningful bias occurred. For the observational study, we reanalyzed data from the United States Influenza VE Network, an ongoing test-negative study. We compared "bias-naïve" VE estimates to bias-adjusted estimates, which used data from the source populations to correct for sampling bias.
RESULTS: In the simulation study, an unmeasured care-seeking proclivity could create selection bias if persons with influenza ARI were more (or less) likely to seek care than persons with non-influenza ARI. However, selection bias was only meaningful when rates of care seeking between influenza ARI and non-influenza ARI were very different. In the observational study, the bias-naïve VE estimate of 55% (95% CI, 47--62%) was trivially different from the bias-adjusted VE estimate of 57% (95% CI, 49--63%).
CONCLUSIONS: In combination, these studies suggest that while selection bias is possible in test-negative VE studies, this bias in unlikely to be meaningful under conditions likely to be encountered in practice. Researchers and public health officials can continue to rely on VE estimates from test-negative studies.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bias (Epidemiology); Human; Influenza; Methodology; Vaccine effectiveness

Mesh:

Substances:

Year:  2017        PMID: 29254838     DOI: 10.1016/j.vaccine.2017.12.022

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Challenges in estimating influenza vaccine effectiveness.

Authors:  Kylie E C Ainslie; Michael Haber; Walt A Orenstein
Journal:  Expert Rev Vaccines       Date:  2019-05-31       Impact factor: 5.217

2.  The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology.

Authors:  Huiying Chua; Shuo Feng; Joseph A Lewnard; Sheena G Sullivan; Christopher C Blyth; Marc Lipsitch; Benjamin J Cowling
Journal:  Epidemiology       Date:  2020-01       Impact factor: 4.822

Review 3.  Variations in Seasonal Influenza Vaccine Effectiveness due to Study Characteristics: A Systematic Review and Meta-analysis of Test-Negative Design Studies.

Authors:  George N Okoli; Florentin Racovitan; Christiaan H Righolt; Salaheddin M Mahmud
Journal:  Open Forum Infect Dis       Date:  2020-05-21       Impact factor: 3.835

4.  Effect of propensity of seeking medical care on the bias of the estimated effectiveness of rotavirus vaccines from studies using a test-negative case-control design.

Authors:  Michael Haber; Benjamin A Lopman; Jacqueline E Tate; Meng Shi; Umesh D Parashar
Journal:  Vaccine       Date:  2019-04-26       Impact factor: 3.641

5.  Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.

Authors:  Emma K Accorsi; Amadea Britton; Katherine E Fleming-Dutra; Zachary R Smith; Nong Shang; Gordana Derado; Joseph Miller; Stephanie J Schrag; Jennifer R Verani
Journal:  JAMA       Date:  2022-02-15       Impact factor: 157.335

6.  Use of self-reported vaccination status can bias vaccine effectiveness estimates from test-negative studies.

Authors:  Michael L Jackson
Journal:  Vaccine X       Date:  2018-12-29

7.  Assessment of demographic and perinatal predictors of non-response and impact of non-response on measures of association in a population-based case control study: findings from the Georgia Study to Explore Early Development.

Authors:  Laura A Schieve; Shericka Harris; Matthew J Maenner; Aimee Alexander; Nicole F Dowling
Journal:  Emerg Themes Epidemiol       Date:  2018-08-16

8.  Prospective cohort study of influenza vaccine effectiveness among healthcare personnel in Lima, Peru: Estudio Vacuna de Influenza Peru, 2016-2018.

Authors:  Meredith G Wesley; Giselle Soto; Carmen Sofia Arriola; Miriam Gonzales; Gabriella Newes-Adeyi; Candice Romero; Vic Veguilla; Min Z Levine; Maria Silva; Jill M Ferdinands; Fatimah S Dawood; Sue B Reynolds; Avital Hirsch; Mark Katz; Eduardo Matos; Eduardo Ticona; Juan Castro; Maria Castillo; Eduar Bravo; Angela Cheung; Rachel Phadnis; Emily Toth Martin; Yeny Tinoco; Joan Manuel Neyra Quijandria; Eduardo Azziz-Baumgartner; Mark G Thompson
Journal:  Influenza Other Respir Viruses       Date:  2020-04-05       Impact factor: 4.380

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.